Cumulative expression of the two Lyn isoforms creates a threshold for macrophage signaling in the absence of receptor engagement
Journal of Leukocyte Biology · 2026
DOI: 10.1093/jleuko/qiag133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2026. Verfasst von S Erandika Senevirathne und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Molecular Pharmacology and Therapeutics, University of Minnesota, 2101 6th Street SE, Minneapolis, MN 55455, United States. Hauptthemen laut MEDLINE: src-Family Kinases, Signal Transduction, Macrophages. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIAMS NIH HHS, University of Minnesota.
Abstract (Originalsprache)
It has been unclear whether phenotypic differences between LynA- and LynB-knockout mice, each expressing only one splice form of the Src-family kinase (SFK) Lyn, are due to isoform-specific functions or dose effects from differences in overall Lyn expression. To assess the functions of LynA and LynB, we generated a genetic series in which LynA and LynB expression levels vary independently, allowing us to test whether upregulation of one Lyn isoform could compensate for loss of the other. We used macrophages from this dose series to test signaling at steady state and in response to pharmacological pan-SFK activation. We found that LynA and LynB are equally capable of phosphorylating the positive-regulatory tyrosine kinase Syk and the negative-regulatory inositol phosphatase SHIP1, to a level determined by the cumulative expression level of LynA + LynB protein at steady state. Despite the dependence of steady-state and induced phosphorylation of upstream signaling intermediates on the level of Lyn expression, Erk and Akt signaling in response to pan-SFK activation is enabled by any Lyn expression, insensitive to further upregulation of either isoform. Thus, expression of either LynA or LynB at steady state leads to balanced potential for positive-regulatory and negative-regulatory signaling, setting a maximal response in the absence of a microbial encounter.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program in Molecular Pharmacology and Therapeutics, University of Minnesota, 2101 6th Street SE, Minneapolis, MN 55455, United States.
- Department of Pharmacology, University of Minnesota, 2101 6th Street SE, Minneapolis, MN 55455, United States.
- Medical Scientist Training Program, University of Minnesota, 2101 6th Street SE, Minneapolis, MN 55455, United States.
- Graduate Program in Microbiology, Immunology, and Cancer Biology, 2101 6th Street SE, University of Minnesota, Minneapolis, MN 55455, United States.
- Center for Immunology, University of Minnesota, 2101 6th Street SE, Minneapolis, MN 55455, United States.
- Masonic Cancer Center, University of Minnesota, 2101 6th Street SE, Minneapolis, MN 55455, United States.
ORCID-Profile: S Erandika Senevirathne, Siyu Jin, Carter E Sellner, Silvia Toledo Ramos, Tanya S Freedman
Förderung
- NIH HHS
- NIAMS NIH HHS
- University of Minnesota
- Undergraduate Research Opportunities Program Award
- National Institutes of Health
Zitieren
APA
Senevirathne, S. E., Jin, S., Sellner, C. E., Ramos, S. T., & Freedman, T. S. (2026). Cumulative expression of the two Lyn isoforms creates a threshold for macrophage signaling in the absence of receptor engagement. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiag133
Vancouver
Senevirathne SE, Jin S, Sellner CE, Ramos ST, Freedman TS. Cumulative expression of the two Lyn isoforms creates a threshold for macrophage signaling in the absence of receptor engagement. Journal of Leukocyte Biology. 2026. doi:10.1093/jleuko/qiag133
BibTeX
@article{Senevirathne2026,
author = {Senevirathne, S Erandika and Jin, Siyu and Sellner, Carter E and Ramos, Silvia Toledo and Freedman, Tanya S},
title = {Cumulative expression of the two Lyn isoforms creates a threshold for macrophage signaling in the absence of receptor engagement},
journal = {Journal of Leukocyte Biology},
year = {2026},
doi = {10.1093/jleuko/qiag133}
}
EUVIMED